Sign in
4

Changes in Ownership

DEXCOM INC Filed Acc 0001093557-25-000288

Director sold 2,906 shares at $59.05 ($171,599)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Collins Richard Alexander Director 2025-11-14 Sale 10b5-1 −2,906 $59.05 $171,599 35,088 I: show line 1 in the form
Open-market sales · 2,906 sh · avg $59.05 · $171,599
Loading xslF345X05/wk-form4_1763419953.xml…